CorMedix Inc. (CRMD)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $610.36M
- P/E ratio
- —
- EPS
- —
- Volume
- 1,155,885
- 52-week high
- —
- 52-week low
- —
- Open
- $8.48
- Day high
- $8.53
- Day low
- $7.70
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $311.71M | $163.06M | $2.04 |
| 2024 | $43.47M | -$17.93M | -$0.30 |
| 2023 | — | -$46.34M | -$0.91 |
| 2022 | $65.41K | -$29.7M | -$0.74 |
| 2021 | $190.94K | -$28.21M | -$0.75 |
About CorMedix Inc.
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
- CEO
- Joseph Todisco
- Employees
- 191
- Country
- US
- IPO date
- May 13, 2010
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is CorMedix Inc.'s stock price today?
- CRMD is trading at $7.78 as of Jul 20, 2026.
- What is CorMedix Inc.'s market cap?
- CorMedix Inc. (CRMD) has a market capitalization of $610.36M.
- Does CorMedix Inc. pay a dividend?
- CorMedix Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is CorMedix Inc. in?
- CorMedix Inc. operates in the Healthcare sector.